A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Daxor Corp stock. As of the latest transaction made, Renaissance Technologies LLC holds 14,821 shares of DXR stock, worth $129,239. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,821
Previous 15,121 1.98%
Holding current value
$129,239
Previous $140,000 8.57%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$7.86 - $9.7 $2,358 - $2,910
-300 Reduced 1.98%
14,821 $128,000
Q2 2024

Aug 09, 2024

SELL
$0.0 - $9.94 $0 - $1,988
-200 Reduced 1.31%
15,121 $140,000
Q4 2023

Feb 13, 2024

SELL
$7.26 - $9.6 $3,630 - $4,800
-500 Reduced 3.16%
15,321 $147,000
Q3 2023

Nov 14, 2023

BUY
$9.03 - $10.15 $4,515 - $5,075
500 Added 3.26%
15,821 $148,000
Q2 2023

Aug 11, 2023

BUY
$9.51 - $13.03 $1,902 - $2,606
200 Added 1.32%
15,321 $147,000
Q1 2023

May 12, 2023

SELL
$8.25 - $11.23 $16,500 - $22,460
-2,000 Reduced 11.68%
15,121 $166,000
Q4 2022

Feb 13, 2023

BUY
$9.1 - $13.63 $1,820 - $2,726
200 Added 1.18%
17,121 $157,000
Q3 2022

Nov 14, 2022

SELL
$12.1 - $14.23 $50,820 - $59,766
-4,200 Reduced 19.89%
16,921 $224,000
Q2 2022

Aug 12, 2022

SELL
$10.62 - $13.21 $13,805 - $17,173
-1,300 Reduced 5.8%
21,121 $279,000
Q1 2022

May 13, 2022

BUY
$10.51 - $11.52 $6,306 - $6,912
600 Added 2.75%
22,421 $239,000
Q4 2021

Feb 11, 2022

SELL
$10.59 - $11.5 $16,944 - $18,400
-1,600 Reduced 6.83%
21,821 $246,000
Q3 2021

Nov 12, 2021

SELL
$8.77 - $12.05 $4,385 - $6,025
-500 Reduced 2.09%
23,421 $274,000
Q2 2021

Aug 13, 2021

SELL
$8.9 - $14.15 $9,790 - $15,565
-1,100 Reduced 4.4%
23,921 $254,000
Q1 2021

May 13, 2021

SELL
$11.02 - $13.86 $5,510 - $6,930
-500 Reduced 1.96%
25,021 $303,000
Q4 2020

Feb 10, 2021

SELL
$12.15 - $15.77 $48,600 - $63,080
-4,000 Reduced 13.55%
25,521 $319,000
Q3 2020

Nov 13, 2020

BUY
$14.66 - $23.78 $58,640 - $95,120
4,000 Added 15.67%
29,521 $465,000
Q2 2020

Aug 13, 2020

BUY
$12.83 - $15.83 $151,650 - $187,110
11,820 Added 86.27%
25,521 $374,000
Q1 2020

May 14, 2020

BUY
$8.6 - $14.25 $22,368 - $37,064
2,601 Added 23.43%
13,701 $185,000
Q3 2019

Nov 13, 2019

BUY
$7.81 - $9.87 $4,686 - $5,921
600 Added 5.71%
11,100 $107,000
Q2 2019

Aug 12, 2019

SELL
$7.5 - $11.61 $15,000 - $23,220
-2,000 Reduced 16.0%
10,500 $83,000
Q1 2019

May 14, 2019

BUY
$9.11 - $19.52 $4,555 - $9,760
500 Added 4.17%
12,500 $141,000
Q4 2018

Feb 13, 2019

BUY
$4.7 - $9.55 $56,400 - $114,600
12,000 New
12,000 $98,000

Others Institutions Holding DXR

About DAXOR CORP


  • Ticker DXR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 4,041,670
  • Market Cap $35.2M
  • Description
  • Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used i...
More about DXR
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.